Cannabis and Cannabis-Derived Products must be produced in compliance with Good Agricultural and Collection Practices (GACP), Good Production Practices (GPP) and Good Manufacturing Practices (GMP).
Using cannabis in medicine means its cultivation must abide strict quality standards such as the Good Production Practices (GPP); the GMP (Good Manufacturing Practices) and the GACP (Good Agricultural and Collection Practices).
Mivado GP consultants will help and support your facility to comply with GACP, GPP and GMP by devlopping and Implementing a cost-effective Quality Assurance Program as per Health Canada, EU GMP, and US FDA regulations.
GACP
Implementation and deployment of GACP (Good Agricultural and Collection Practices) as set of guidelines, SOPs and policies covering areas of cultivation (from seeds and propagation material), collection, harvest, processing, packaging, personnel, equipment, documentation and others for the sake of satisfying the minimum required quality assurance in plant cultivation.
GPP
Cannabis is considered a medicinal plant regardless whether cultivated for recreational or pharmaceutical use. We support implementing quality system because Cannabis facilities must be constructed and operated to meet GPP standards and to ensure cannabis is produced in a contamination-free environment so that will maintain its quality.
GMP
GACP and GPP Together with GMP, these guidelines completely define the entire process from seed to sale of all plants with Active Pharmaceutical Ingredients (APIs) to which cannabis belongs to. GMP is to ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production.
